CompareMarketResearchRequest a sample
Home / Healthcare / Proton Therapy

Healthcare · Market report

Proton Therapy Market Size, Share and Forecast 2026-2036

The global proton therapy market is worth USD 1.4 bn in 2026 and is forecast to reach USD 2.9 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Multi-room is the largest by system type segment.

USD 1.4 bnMarket size 2026
USD 2.9 bnForecast 2036
8.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global proton therapy market is worth USD 1.4 bn in 2026 and is forecast to reach USD 2.9 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Multi-room is the largest by system type segment.

ScopeProton therapy systems for cancer radiotherapy: accelerators, gantries and treatment rooms, with installation, upgrades and service contracts.
IndustryHealthcare
Value 2025USD 1.2 bn
Value 2026USD 1.4 bn
Value 2036USD 2.9 bn
CAGR 2026-20368.0%
Volume 202653.2 treatment rooms
Volume 203699.0 treatment rooms
Average price 2026USD 25,370,000 per treatment room
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Proton Therapy market size and forecast, 2026-2036

Exhibit 1The global proton therapy market is forecast to grow from USD 1.4 bn in 2026 to USD 2.9 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.0%
Proton Therapy market value, 2025 to 2036Market value by year. 2025: USD 1.2 bn; 2026: USD 1.4 bn; 2027: USD 1.5 bn; 2028: USD 1.6 bn; 2029: USD 1.7 bn; 2030: USD 1.8 bn; 2031: USD 2.0 bn; 2032: USD 2.1 bn; 2033: USD 2.3 bn; 2034: USD 2.5 bn; 2035: USD 2.7 bn; 2036: USD 2.9 bn. Compound annual growth rate 2026 to 2036: 8.0%.20251.4 bn20262.0 bn20312.9 bn20368.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 1.4 bn
2027USD 1.5 bn
2028USD 1.6 bn
2029USD 1.7 bn
2030USD 1.8 bn
2031USD 2.0 bn
2032USD 2.1 bn
2033USD 2.3 bn
2034USD 2.5 bn
2035USD 2.7 bn
2036USD 2.9 bn

Proton Therapy market segmentation

By system type

Exhibit 2Multi-room is the largest segment by system type, with 50.0% of 2026 revenueEstimated share of 2026 global revenue, by system type
Proton Therapy market share by system type, 2026Share of 2026 revenue by system type. Multi-room: 50.0%; Single-room compact: 38.0%; Ultra-compact and upright-positioning: 12.0%.Multi-room50.0%Single-room compact38.0%Ultra-compact and upright-positioning12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Multi-room50.0%37.4%USD 675 mn4.9%
Single-room compact38.0%43.1%USD 513 mn9.4%
Ultra-compact and upright-positioning12.0%19.5%USD 162 mn13.4%

By accelerator

Exhibit 3Cyclotron adds the most revenue by accelerator, growing from USD 945 mn in 2026 to USD 1.9 bn by 2036Estimated revenue in USD by accelerator, 2026 and 2036 forecast
Proton Therapy market by accelerator, 2026 and 2036Revenue by accelerator in 2026 and 2036. Cyclotron: USD 945 mn in 2026, USD 1.9 bn in 2036, change +102%; Synchrocyclotron: USD 243 mn in 2026, USD 708 mn in 2036, change +191%; Synchrotron: USD 162 mn in 2026, USD 298 mn in 2036, change +84%.20262036 forecastChangeCyclotron+102%945 mn1.9 bnSynchrocyclotron+191%243 mn708 mnSynchrotron+84%162 mn298 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cyclotron70.0%65.5%USD 945 mn7.3%
Synchrocyclotron18.0%24.3%USD 243 mn11.3%
Synchrotron12.0%10.2%USD 162 mn6.3%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals55.0%55.3%USD 742 mn8.1%
Cancer centres30.0%31.6%USD 405 mn8.6%
Research institutes15.0%13.1%USD 202 mn6.6%

By treatment site

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Prostate36.0%34.0%USD 486 mn7.4%
Head and neck20.0%20.0%USD 270 mn8.0%
Brain and spine12.0%12.0%USD 162 mn8.0%
Breast12.0%14.0%USD 162 mn9.7%
Lung and other20.0%20.0%USD 270 mn8.0%

By delivery

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Pencil beam scanning62.0%70.0%USD 837 mn9.3%
Passive scattering28.0%16.0%USD 378 mn2.1%
Hybrid and FLASH-ready10.0%14.0%USD 135 mn11.7%

Top 25 countries for proton therapy by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.5% of 2026 revenue and the 25 countries below together hold 94.2%.

Exhibit 4United States is the largest country market at USD 405 mn in 2026, and the three largest countries hold 54.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Proton Therapy market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 405 mn, 30.0%; Japan: USD 189 mn, 14.0%; China: USD 135 mn, 10.0%; Germany: USD 94 mn, 7.0%; France: USD 54 mn, 4.0%; United Kingdom: USD 54 mn, 4.0%; Netherlands: USD 40 mn, 3.0%; Italy: USD 40 mn, 3.0%; South Korea: USD 40 mn, 3.0%; India: USD 34 mn, 2.5%.United States405 mn 30.0%Japan189 mn 14.0%China135 mn 10.0%Germany94 mn 7.0%France54 mn 4.0%United Kingdom54 mn 4.0%Netherlands40 mn 3.0%Italy40 mn 3.0%South Korea40 mn 3.0%India34 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 405 mn30.0%USD 813 mn7.2%
2JapanUSD 189 mn14.0%USD 344 mn6.2%
3ChinaUSD 135 mn10.0%USD 391 mn11.2%
4GermanyUSD 94 mn7.0%USD 181 mn6.7%
5FranceUSD 54 mn4.0%USD 108 mn7.2%
6United KingdomUSD 54 mn4.0%USD 108 mn7.2%
7NetherlandsUSD 40 mn3.0%USD 82 mn7.3%
8ItalyUSD 40 mn3.0%USD 82 mn7.3%
9South KoreaUSD 40 mn3.0%USD 99 mn9.4%
10IndiaUSD 34 mn2.5%USD 128 mn14.3%
11SwitzerlandUSD 33 mn2.4%USD 71 mn8.0%
12CanadaUSD 26 mn1.9%USD 54 mn7.7%
13AustraliaUSD 19 mn1.4%USD 40 mn7.6%
14SpainUSD 15 mn1.1%USD 32 mn7.6%
15BelgiumUSD 13 mn1.0%USD 27 mn7.7%
16SwedenUSD 11 mn0.8%USD 24 mn7.6%
17TaiwanUSD 10 mn0.8%USD 21 mn7.6%
18Saudi ArabiaUSD 9.2 mn0.7%USD 27 mn11.4%
19AustriaUSD 8.4 mn0.6%USD 17 mn7.7%
20PolandUSD 7.7 mn0.6%USD 23 mn11.4%
21Czech RepublicUSD 7.2 mn0.5%USD 15 mn7.6%
22DenmarkUSD 6.8 mn0.5%USD 14 mn7.6%
23IsraelUSD 6.3 mn0.5%USD 19 mn11.4%
24ThailandUSD 5.9 mn0.4%USD 18 mn11.6%
25EgyptUSD 5.7 mn0.4%USD 17 mn11.5%
Rest of worldUSD 79 mn5.8%USD 163 mn7.5%
Exhibit 5United States and China account for 42% of the USD 1.6 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Proton Therapy market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 1.4 bn. United States: +USD 408 mn; China: +USD 256 mn; Japan: +USD 155 mn; India: +USD 94 mn; Germany: +USD 86 mn; 20 other countries: +USD 481 mn; Rest of world: +USD 84 mn. Market value 2036: USD 2.9 bn.Market value 20261.4 bnUnited States+408 mnChina+256 mnJapan+155 mnIndia+94 mnGermany+86 mn20 other countries+481 mnRest of world+84 mnMarket value 20362.9 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • IBA
  • Varian
  • Hitachi
  • Sumitomo Heavy Industries

Group 2: Regional and specialist players

  • Mevion Medical Systems
  • Mitsubishi Electric
  • Toshiba Energy Systems
  • Optivus Proton Therapy
  • Shanghai APACTRON Particle Equipment

Group 3: Emerging and niche players

  • ProTom International
  • CAS Ion Medical and Technology
  • P-Cure
  • Advanced Oncotherapy

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the proton therapy market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.

The market is divided by system type, by accelerator, by end user, by treatment site, by delivery. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the proton therapy market?

The global proton therapy market is estimated at USD 1.2 bn in 2025 and USD 1.4 bn in 2026.

How fast will the proton therapy market grow?

It is forecast to reach USD 2.9 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 1.6 bn.

Which country is the largest market for proton therapy?

United States is the largest market by revenue at USD 405 mn in 2026, 30.0% of the global total. The three largest countries together hold 54.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 14.3% a year from 2026 to 2036.

Which proton therapy segment is largest?

In the by system type split, Multi-room is the largest segment with 50.0% of 2026 revenue.

Who are the leading proton therapy companies?

Global leaders include IBA, Varian, Hitachi, Sumitomo Heavy Industries.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Protein-Free Nutrition Module RNA Therapeutics →

All Healthcare markets →

Request a sample